Literature DB >> 28730100

Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye.

Seung Min Lee1,2, Jae Woo Jung1,2, Sung Who Park2,3, Ji Eun Lee2,3, Ik Soo Byon1,2.   

Abstract

Entities:  

Year:  2017        PMID： 28730100      PMCID： PMC5515166          DOI： 10.18240/ijo.2017.06.31

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  7 in total

1.  Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous.

Authors:  B Lee; M Litt; G Buchsbaum
Journal:  Biorheology       Date:  1992 Sep-Dec       Impact factor: 1.875

Review 2.  The biochemical structure of mammalian vitreous.

Authors:  P Bishop
Journal:  Eye (Lond)       Date:  1996       Impact factor: 3.775

3.  Kinematic study of ozurdex injection in balanced salt solution: modeling the behavior of an injectable drug delivery device in vitrectomized eyes.

Authors:  Ronakorn Panjaphongse; Weifeng Liu; Pear Pongsachareonnont; Jay M Stewart
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-08       Impact factor: 2.671

4.  A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).

Authors:  Ling Zhi Heng; Sobha Sivaprasad; Roxanne Crosby-Nwaobi; Zubin Saihan; Mike Karampelas; Catey Bunce; Tunde Peto; Philip G Hykin
Journal:  Br J Ophthalmol       Date:  2015-10-15       Impact factor: 4.638

5.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

6.  Inadvertent dexamethasone implant injection into the lens body management.

Authors:  Antonio Berarducci; Inderpaul S Sian; Roland Ling
Journal:  Eur J Ophthalmol       Date:  2014-02-03       Impact factor: 2.597

7.  Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.

Authors:  Javier Coca-Robinot; Bruno Casco-Silva; Felix Armadá-Maresca; Jesús García-Martínez
Journal:  Eur J Ophthalmol       Date:  2014-02-25       Impact factor: 2.597
  7 in total
  3 in total

1.  Retinal injury following intravitreal injection of a dexamethasone implant in a non-vitrectimised eye.

Authors:  M Arvind Jain; Amishi Khanna; V Narendran
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

2.  Suprachoroidal injection of triamcinolone acetonide using a custom-made needle to treat diabetic macular edema post pars plana vitrectomy: a case series.

Authors:  Ameen Marashi; Aya Zazo
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

3.  [Loss of vision after intravitreal dexamethasone injection in a vitrectomized eye].

Authors:  Victoria Reitmeier; Christoph Kern; Maria Poimenidou; Ines M Lanzl
Journal:  Ophthalmologe       Date:  2021-03-12       Impact factor: 1.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.